Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127217302 | 12721730 | 2 | F | 20160830 | 20160907 | 20160914 | EXP | TW-MYLANLABS-2016M1037709 | MYLAN | CHANG C, CHAN H, SUN H, CHANG T.. DEATH OF THREE PATIENTS WITH SCHIZOPHRENIA DURING CLOZAPINE TREATMENT.. TAIWANESE JOURNAL OF PSYCHIATRY. 2001;15:158-64 | 0.00 | Y | 0.00000 | 20160914 | OT | TW | TW |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127217302 | 12721730 | 1 | PS | CLOZAPINE. | CLOZAPINE | 1 | UNK | 75417 | |||||||||||
| 127217302 | 12721730 | 2 | SS | CLOZAPINE. | CLOZAPINE | 1 | 400 MG, QD | 75417 | 400 | MG | QD | ||||||||
| 127217302 | 12721730 | 3 | SS | CLOZAPINE. | CLOZAPINE | 1 | 200 MG, QD | 75417 | 200 | MG | QD | ||||||||
| 127217302 | 12721730 | 4 | SS | CLOZAPINE. | CLOZAPINE | 1 | 400 MG, QD | 75417 | 400 | MG | QD | ||||||||
| 127217302 | 12721730 | 5 | SS | CLOZAPINE. | CLOZAPINE | 1 | 500 MG, UNK | 75417 | 500 | MG | |||||||||
| 127217302 | 12721730 | 6 | SS | MIDAZOLAM | MIDAZOLAMMIDAZOLAM HYDROCHLORIDE | 1 | 15 MG, UNK | 0 | 15 | MG | |||||||||
| 127217302 | 12721730 | 7 | SS | LORAZEPAM. | LORAZEPAM | 1 | Intramuscular | 4 MG, UNK | 0 | 4 | MG | ||||||||
| 127217302 | 12721730 | 8 | SS | LORAZEPAM. | LORAZEPAM | 1 | Intramuscular | UNK | 0 | ||||||||||
| 127217302 | 12721730 | 9 | SS | ESTAZOLAM. | ESTAZOLAM | 1 | Oral | 2 MG, QD | 0 | 2 | MG | QD | |||||||
| 127217302 | 12721730 | 10 | SS | ESTAZOLAM. | ESTAZOLAM | 1 | Oral | 2 MG, UNK | 0 | 2 | MG | ||||||||
| 127217302 | 12721730 | 11 | SS | ESTAZOLAM. | ESTAZOLAM | 1 | Oral | 4 MG, UNK | 0 | 4 | MG | ||||||||
| 127217302 | 12721730 | 12 | C | HALOPERIDOL. | HALOPERIDOL | 1 | UNK | 0 | |||||||||||
| 127217302 | 12721730 | 13 | C | HALOPERIDOL. | HALOPERIDOL | 1 | 7.5 MG, UNK | 0 | 7.5 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127217302 | 12721730 | 1 | Schizophrenia |
| 127217302 | 12721730 | 6 | Product used for unknown indication |
| 127217302 | 12721730 | 7 | Product used for unknown indication |
| 127217302 | 12721730 | 9 | Product used for unknown indication |
| 127217302 | 12721730 | 12 | Schizophrenia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127217302 | 12721730 | HO |
| 127217302 | 12721730 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127217302 | 12721730 | Asthenia | |
| 127217302 | 12721730 | Cardiac failure | |
| 127217302 | 12721730 | Respiratory failure | |
| 127217302 | 12721730 | Somnolence | |
| 127217302 | 12721730 | Sudden death | |
| 127217302 | 12721730 | Tachycardia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |